Special Issue "Breast Cancer: From Pathophysiology to Novel Therapeutic Approaches"
Deadline for manuscript submissions: 30 September 2020.
Breast cancer remains the most frequent cancer in women and has different patterns of disease progression and response to treatments. The wide variation in patient prognosis and outcomes is due to the high heterogeneity of this disease. Current studies are focusing on the identification of novel biomarkers and the elucidation of the altered molecular mechanisms underlying the behavior of different subtypes of breast cancer. The results of these investigations are allowing for the development of novel targeted therapies that, either alone or in combination with conventional radio- and chemotherapy, could be promising management strategies for more effective and personalized therapies.
This Special Issue “Breast Cancer: From Pathophysiology to Novel Therapeutic Approaches” of the International Journal of Molecular Sciences aims at providing an updated overview of pre-clinical and clinical knowledge on the pathophysiology and molecular profiling of breast cancer as well as on the development of innovative targeted therapeutic approaches while taking into account promises and pitfalls.
Dr. Antonella Zannetti
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All papers will be peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. International Journal of Molecular Sciences is an international peer-reviewed open access semimonthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. There is an Article Processing Charge (APC) for publication in this open access journal. For details about the APC please see here. Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
- breast cancer
- molecular heterogeneity
- signaling pathways
- targeted therapies
- development of novel drugs
The below list represents only planned manuscripts. Some of these manuscripts have not been received by the Editorial Office yet. Papers submitted to MDPI journals are subject to peer-review.
Title: Advances in immunotherapies for the treatment of Triple-Negative Breast Cancer
Authors: Yasser Heakal, etc.